CN105377259A - 提高药物和膳食补充剂的细胞吸收的方法和产品 - Google Patents

提高药物和膳食补充剂的细胞吸收的方法和产品 Download PDF

Info

Publication number
CN105377259A
CN105377259A CN201480028295.1A CN201480028295A CN105377259A CN 105377259 A CN105377259 A CN 105377259A CN 201480028295 A CN201480028295 A CN 201480028295A CN 105377259 A CN105377259 A CN 105377259A
Authority
CN
China
Prior art keywords
dietary supplement
family member
tetrandrine
tetrandrine family
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480028295.1A
Other languages
English (en)
Chinese (zh)
Inventor
D·L·巴涅特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CBA Pharma Inc
Original Assignee
CBA Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CBA Pharma Inc filed Critical CBA Pharma Inc
Publication of CN105377259A publication Critical patent/CN105377259A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201480028295.1A 2013-03-15 2014-03-12 提高药物和膳食补充剂的细胞吸收的方法和产品 Pending CN105377259A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361793028P 2013-03-15 2013-03-15
US61/793,028 2013-03-15
PCT/US2014/024649 WO2014150959A2 (en) 2013-03-15 2014-03-12 Method and products for enhancing cellular uptake of drug and dietary supplements

Publications (1)

Publication Number Publication Date
CN105377259A true CN105377259A (zh) 2016-03-02

Family

ID=51529978

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480028295.1A Pending CN105377259A (zh) 2013-03-15 2014-03-12 提高药物和膳食补充剂的细胞吸收的方法和产品

Country Status (7)

Country Link
US (1) US9254323B2 (https=)
EP (1) EP3038655A4 (https=)
JP (1) JP2016514143A (https=)
KR (1) KR20150141970A (https=)
CN (1) CN105377259A (https=)
MX (1) MX2015013160A (https=)
WO (1) WO2014150959A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105357966A (zh) * 2013-03-15 2016-02-24 Cba制药公司 提高药物和膳食补充剂的生物利用度的方法和产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124315A (en) * 1989-09-28 2000-09-26 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant disease
CN102600159A (zh) * 2012-03-09 2012-07-25 深圳松乐生物科技有限公司 含有粉防己碱及粉防己碱类衍生物和氟喹诺酮类药物的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332747A (en) 1989-09-28 1994-07-26 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells
AU673142B2 (en) 1991-04-19 1996-10-31 Cba International, Inc. Method for potentiating primary drugs in treating multidrug resistant cells
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6350476B1 (en) 2000-05-22 2002-02-26 Shanxi Zhengzhon Pharmaceutical Co., Ltd. Herbal chinese joint complex
WO2014043347A1 (en) * 2012-09-13 2014-03-20 Cba Pharma, Inc. Mdr method and products for treating mrsa
CN105357966A (zh) * 2013-03-15 2016-02-24 Cba制药公司 提高药物和膳食补充剂的生物利用度的方法和产品

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124315A (en) * 1989-09-28 2000-09-26 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant disease
CN102600159A (zh) * 2012-03-09 2012-07-25 深圳松乐生物科技有限公司 含有粉防己碱及粉防己碱类衍生物和氟喹诺酮类药物的组合物及其应用

Also Published As

Publication number Publication date
EP3038655A2 (en) 2016-07-06
US20140275157A1 (en) 2014-09-18
WO2014150959A2 (en) 2014-09-25
KR20150141970A (ko) 2015-12-21
MX2015013160A (es) 2016-04-04
WO2014150959A3 (en) 2015-01-22
US9254323B2 (en) 2016-02-09
EP3038655A4 (en) 2017-01-18
JP2016514143A (ja) 2016-05-19

Similar Documents

Publication Publication Date Title
CN116785301A (zh) 含醋酸阿比特龙的药物组合物及其制备方法和应用
US20140275139A1 (en) Mdr method and products for treating hiv/aids
WO2024082724A1 (en) Pim kinase inhibitor in combination with kras inhibitor
CN113082039B (zh) 一种用于治疗索拉菲尼耐药肿瘤的组合物及其应用
JP2012505830A5 (https=)
WO2014043347A1 (en) Mdr method and products for treating mrsa
CN105377259A (zh) 提高药物和膳食补充剂的细胞吸收的方法和产品
US9345257B2 (en) Method and products for enhancing drug and dietary supplement bioavailability
CN104936585B (zh) 包括苯肾上腺素和扑热息痛的组合药剂
KR20180039187A (ko) 게실증의 치료를 위한 방법 및 조성물
US20140275138A1 (en) Method and products for treating diabetes
CN104398517A (zh) 乙胺嘧啶的新用途及治疗肿瘤的药物组合物
JP5241127B2 (ja) 鎮痛用組成物
CN111558045A (zh) 一种治疗肺癌的药物组合物
CN106806382B (zh) 抗癌组合物
CN115089576B (zh) 木犀草素和菊苣酸联合在制备乳腺癌治疗药物中的应用
JP2014097968A (ja) 医薬組成物
CN103263405B (zh) 用于治疗糖尿病的药物组合物及其应用
JP2007137896A (ja) イブプロフェン含有医薬製剤
Murali Treatment of Iron Deficiency After Gastric Bypass—Reply
CN117180264A (zh) 五味子乙素在制备镇痛药物中的应用
Doshi et al. Furazolidone (Furazolidine)
CN117752665A (zh) 熊果酸作为柳氮磺吡啶抗肝癌增敏剂的用途
CN100406064C (zh) 用于治疗由幽门螺杆菌感染引起的疾病的制剂
CN102309492A (zh) 一种替加氟、吉美斯特和奥替拉西钾复方注射液

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160302